The HiTES Platform

Although historically prolific, recent investments into natural products have delivered diminishing returns due to the costly rediscovery of known compounds. This is in part due to the silent nature of most biosynthetic genes: conventional methods only capture ~10% of a bacterium’s biosynthetic potential.

Using a broadly applicable, high-throughput, genetics-free, and cloning-free approach, the Cryptyx platform, HiTES (High-Throughput Elicitor Screening), accesses 90% of this silent biosynthetic potential in a rapid and parallel manner.